The global surgical sealants and adhesives market was valued at $1,993 million in 2016, and is expected to reach $3,794 million by 2023, registering a CAGR of 9.7% from 2017 to 2023. Surgical sealants and adhesives are preferred over traditional closure methods such as wires, sutures, and staples, as these techniques create immediate and proper sealing. Surgical sealants and adhesives are expected to replace sutures and staples, owing to their improved closure capabilities, less blood loss, higher implementation rate facilitating less painful operation. Moreover, they are applicable in various surgeries such as central nervous system, general surgery, cardiovascular, pulmonary, ophthalmology, orthopedic, urology, and other surgeries.
Urgent need to minimize blood loss in patients and increase in cases of surgical procedures occurring across different countries are the key factors driving the growth of the surgical sealants and adhesives market. Furthermore, surge in adoption of technological advanced products along with certification by regulatory authorities is expected to boost the market growth. However, improper reimbursements in case of surgical adhesive and high costs along with huge data requirements for clinical study designing & launching new products are the factors that hamper the growth of the market. On the contrary, upsurge in demand for surgical sealants & adhesives across the emerging nations is anticipated to offer lucrative growth opportunities for the market.
The global surgical sealants and adhesives market is segmented based on product, indication, application, and region. On the basis of product, the market is bifurcated into natural/biological sealants & adhesives and synthetic & semisynthetic sealants and adhesives. Natural/biological sealants and adhesives are further segmented into by type and by origin. By type, natural/biological sealants and adhesives are classed into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and adhesives are subsegmented into fibrin based, collagen based, based, and albumin based. Polysaccharide-based sealants and adhesives are further classified into chitosan based and other polysaccharide based. By origin, natural/biological sealants and adhesives are divided into animal based, human based, and plant based. Synthetic & semisynthetic sealants and adhesives are further segmented into cyanoacrylates, polyethylene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based on indication is fragmented into tissue sealing & hemostasis and tissue engineering. The applications covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
This report offers a detailed quantitative analysis of the current trends and future estimations from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product
Natural/Biological Sealants and Adhesives
By Type
Polypeptide/Protein-based Sealants and Adhesives
Fibrin Based
Collagen Based
Gelatin Based
Albumin Based
Polysaccharide-based Sealants and Adhesives
Chitosan Based
Other Polysaccharide Based
By Origin
Human Blood Based
Animal Based
Plant Based
Synthetic and Semisynthetic Sealants and Adhesives
Cyanoacrylates
Polyethylene Glycol-based Hydrogel
Urethane-based Adhesives
Other Synthetic Sealants and Adhesives
By Indication
Tissue Sealing and Hemostasis
Tissue Engineering
By Application
Central Nervous System (CNS) Surgeries
General Surgeries
Cardiovascular Surgeries
Orthopedic Surgeries
Cosmetic Surgeries
Ophthalmic Surgeries
Urological Surgeries
Pulmonary Surgeries
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
Republic of South Africa
Rest of LAMEA
KEY PLAYERS PROFILED
Baxter International Inc.
B. Braun Melsungen AG
Cohera Medical, Inc.
CryoLife Inc.
C.R. Bard Inc.
CSL Limited (CSL Behring)
Johnson & Johnson (Ethicon, Inc.)
Ocular Therapeutix Inc.
Sanofi
Sealantis Ltd.
Urgent need to minimize blood loss in patients and increase in cases of surgical procedures occurring across different countries are the key factors driving the growth of the surgical sealants and adhesives market. Furthermore, surge in adoption of technological advanced products along with certification by regulatory authorities is expected to boost the market growth. However, improper reimbursements in case of surgical adhesive and high costs along with huge data requirements for clinical study designing & launching new products are the factors that hamper the growth of the market. On the contrary, upsurge in demand for surgical sealants & adhesives across the emerging nations is anticipated to offer lucrative growth opportunities for the market.
The global surgical sealants and adhesives market is segmented based on product, indication, application, and region. On the basis of product, the market is bifurcated into natural/biological sealants & adhesives and synthetic & semisynthetic sealants and adhesives. Natural/biological sealants and adhesives are further segmented into by type and by origin. By type, natural/biological sealants and adhesives are classed into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and adhesives are subsegmented into fibrin based, collagen based, based, and albumin based. Polysaccharide-based sealants and adhesives are further classified into chitosan based and other polysaccharide based. By origin, natural/biological sealants and adhesives are divided into animal based, human based, and plant based. Synthetic & semisynthetic sealants and adhesives are further segmented into cyanoacrylates, polyethylene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based on indication is fragmented into tissue sealing & hemostasis and tissue engineering. The applications covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
This report offers a detailed quantitative analysis of the current trends and future estimations from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product
Natural/Biological Sealants and Adhesives
By Type
Polypeptide/Protein-based Sealants and Adhesives
Fibrin Based
Collagen Based
Gelatin Based
Albumin Based
Polysaccharide-based Sealants and Adhesives
Chitosan Based
Other Polysaccharide Based
By Origin
Human Blood Based
Animal Based
Plant Based
Synthetic and Semisynthetic Sealants and Adhesives
Cyanoacrylates
Polyethylene Glycol-based Hydrogel
Urethane-based Adhesives
Other Synthetic Sealants and Adhesives
By Indication
Tissue Sealing and Hemostasis
Tissue Engineering
By Application
Central Nervous System (CNS) Surgeries
General Surgeries
Cardiovascular Surgeries
Orthopedic Surgeries
Cosmetic Surgeries
Ophthalmic Surgeries
Urological Surgeries
Pulmonary Surgeries
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
Republic of South Africa
Rest of LAMEA
KEY PLAYERS PROFILED
Baxter International Inc.
B. Braun Melsungen AG
Cohera Medical, Inc.
CryoLife Inc.
C.R. Bard Inc.
CSL Limited (CSL Behring)
Johnson & Johnson (Ethicon, Inc.)
Ocular Therapeutix Inc.
Sanofi
Sealantis Ltd.
Frequently Asked Questions about the Global Surgical Sealants and Adhesives Market
What is the estimated value of the Global Surgical Sealants and Adhesives Market?
What is the growth rate of the Global Surgical Sealants and Adhesives Market?
What is the forecasted size of the Global Surgical Sealants and Adhesives Market?
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT
CHAPTER 5: SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION
CHAPTER 6: SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION
CHAPTER 7: SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
Executive Summary
According to a new report titled, Surgical sealants and adhesives Market by Product, Indication, Application, and Geography: Global Opportunity Analysis and Industry Forecast, 2017-2023" the global surgical sealants and adhesives market accounted for $1,993 million in 2016, and is expected to reach $3,794 million by 2023 with a CAGR of 9.7% from 2017 to 2023. North America is the highest contributor in the surgical sealants and adhesives market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.Adhesives and sealants are used during surgical procedures to reinforce surgical wounds, repair injured tissues, or even replace common suturing techniques. These products can be used as adjuncts to sutures to prevent air and liquid leakages. They can be developed naturally or synthetically, and are used generate three-dimensional networks, which bind to the target tissues and act as sealants, hemostats, or adhesives.
The major driving factors of surgical sealants and adhesives market are rise in geriatric population, surge in prevalence of chronic diseases, and increase in awareness towards the benefits of using surgical sealants and adhesives. Furthermore, increase in number of surgical procedures globally and adoption of technologically advanced products fuel the growth of this market. However, rise in popularity of minimally invasive surgeries, high cost of these sealants and adhesive agents, and requirement of large amount of clinical data for the launch of new products are expected to hamper the market growth.
Among the product segment, natural sealants and adhesives dominates the market, as these products cause less immunogenic reaction, are available abundantly, and are thus less expensive as compared to synthetic products. However, the synthetic and semisynthetic sealants and adhesives segment registers the highest growth rate, as these products are more durable and flexible in nature.
Among the indication segment, tissue engineering is anticipated to grow at the highest rate, owing to upsurge in demand for tissue regeneration products in case of traumatic & burn injuries and rise in number of cosmetic surgeries.
According to Garima Chandra, Research Analyst, Healthcare at Allied Market Research, Increase in number of surgical procedures globally, surge in demand to minimize blood loss in patients, and increase in awareness towards the potential benefits of using surgical sealants and adhesives over traditional methods are the major driving factors of the market.
Key findings of the Surgical Sealants and Adhesives Market:
Cosmetic surgery is projected to grow at the highest rate during the forecast period both in terms of value and volume by 12.2% and 12.7% respectively.
North America dominated the global surgical sealants and adhesives market in 2016, and is projected to continue its dominance in future.
China is expected to grow at the highest rate in the Asia-Pacific region during the forecast period.
Tissue sealing & hemostasis was the largest contributor among the end user segment in 2016.
Cardiovascular surgery segment generated the highest revenue in 2016, and is expected to continue its dominance in future.
In terms of volume fibrin based accounted for the largest share in 2016, registering a CAGR of 8.5% during the forecast period.
Chitosan based dominated the polysaccharide natural surgical sealants and adhesive segment in terms of volume in 2016.
In 2016, North America was the dominant revenue contributor, owing to high prevalence of chronic diseases, increase in disposable income, and surge in number of surgical procedures. However, Asia-Pacific is witnessing the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of chronic diseases, geriatric population, and the number of cosmetic surgeries being conducted.
The key players operating in the global surgical sealants and adhesives market include Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., C.R. Bard Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), Ocular Therapeutix Inc., Sanofi, and Sealantis Ltd.
Other prominent players in the value chain include Vivostat A/S, Medtronic plc, Mallinckrodt plc, Cardinal Health, Integra LifeSciences Holdings Corporation, and LifeBond Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
